SOPHiA GENETICS has partnered with Indian molecular diagnostics service provider Dhiti Omics to improve tumor testing services in India.
Through this partnership, Dhiti Omics will employ SOPHiA GENETICS' SOPHiA DDM technology, the Agilent SureSelect Cancer CGP application, and its best-in-class genomic profiling assay kit to amplify the detection and analysis of gene mutations and biomarkers.
This collaboration will support Dhiti Omics in enhancing the speed and accuracy of solid tumor testing to best support the population demographic.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.